pRSET A, B, & C Bacterial Expression Vectors
Product Image
Invitrogen™

pRSET A, B, & C Bacterial Expression Vectors

El vector pRSET está diseñado para la expresión procariota de alto nivel controlada por el potente promotor T7 bacteriófago. LaMás información
Have Questions?
Número de catálogoCantidad
V3512020μg
Número de catálogo V35120
Precio (MXN)
-
Cantidad:
20μg
El vector pRSET está diseñado para la expresión procariota de alto nivel controlada por el potente promotor T7 bacteriófago. La expresión es inducida por la producción de ARN polimerasa T7 en BL21(DE3) E. coli. Estas células también producen lisozima T7 para reducir la expresión basal de genes diana. El vector pRSET ofrece:

• Promotor T7 bacteriófago para la expresión de alto nivel
• Secuencia del gen 10 T7 para proporcionar estabilidad de proteínas
• Etiqueta polihistidina (6xHis) N-terminal para una rápida purificación con resina quelante de níquel y detección con anticuerpos Anti-HisG
• Epítopo N-terminal Xpress™ para la detección con el anticuerpo Anti-Xpress™
• Sitio de escisión de enterocinasa para la eliminación de la etiqueta de fusión

Se proporciona un conjunto de tres vectores (A, B y C). Cada uno tiene la secuencia de codificación de etiqueta N-terminal en un marco de lectura diferente en relación con el sitio de clonación múltiple para simplificar la clonación sin cambio de pauta de lectura del gen.
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Resistencia bacteriana a los antibióticosAmpicilina (AMPR)
HendiduraSitio de reconocimiento de EK (enterocinasa)
Sistema constitutivo o inducibleInducible
Agente inductorIPTG
Tipo de productoVector de expresión bacteriana
Cantidad20μg
Agente de selección (eucariótico)Ninguno
VectorpRSET
Método de clonaciónEnzimas de restricción/MCS
PromotorT7
Etiqueta de proteínaEtiqueta His (6x)
Unit Size20 µg
Contenido y almacenamiento
Se suministran 20 μg de cada vector pRSET A, B & C liofilizados. También se incluyen los medios de control de E. coli TOP10F´ BL21(DE3)pLysS y BL21 pRSET/lacZ. Conserve losmedios de E. coli a 2–8°C. Se garantiza la estabilidad de todos los componentes durante 6 meses si se almacenan correctamente.

Preguntas frecuentes

My gene of interest is toxic to bacterial cells. Are there any precautions you can suggest?

Several precautions may be taken to prevent problems resulting from basal level expression of a toxic gene of interest. These methods all assume that the T7-based or Champion-based expression plasmid has been correctly designed and created.

- Propagate and maintain your expression plasmid in a strain that does not contain T7 RNA polymerase (i.e., DH5α).
- If using BL21 (DE3) cells, try growing cells at room temperature rather than 37 degrees C for 24-48 hr.
- Perform a fresh transformation using a tightly regulated E. coli strain, such as BL21-AI cells.
- After following the transformation protocol, plate the transformation reaction on LB plates containing 100 µg/mL ampicillin and 0.1% glucose. The presence of glucose represses basal expression of T7 RNA polymerase.
- Following transformation of BL21-AI cells, pick 3 or 4 transformants and inoculate directly into fresh LB medium containing 100 µg/mL ampicillin or 50 µg/mL carbenicillin (and 0.1% glucose, if desired). When the culture reaches an OD600 of 0.4, induce expression of the recombinant protein by adding L-arabinose to a final concentration of 0.2%.
- When performing expression experiments, supplement the growth medium with 0.1% glucose in addition to 0.2% arabinose.
- Try a regulated bacterial expression system such as our pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm trying to express my protein using a bacterial expression system. How do I know if I'm seeing degradation of my protein or if what I’m seeing is codon usage bias?

Typically, if you see 1-2 dominant bands, translation stopped prematurely due to codon usage bias. With degradation, you usually see a ladder of bands. With degradation, you can try using a protease inhibitor and add it to the lysis buffer to help prevent degradation. If degradation is the issue, a time point experiment can be done to determine the best time to harvest the cells.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm trying to express my protein using a bacterial expression system and am getting inclusion bodies. What should I do?

If you are having a solubility issue, try to decrease the temperature or decrease the amount of IPTG used for induction. You can also try a different, more stringent cell strain for expression. Adding 1% glucose to the bacterial culture medium during expression can also help.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm getting low protein yield from my bacterial expression system. What can I do to improve this?

- Inoculate from fresh bacterial cultures, since higher protein yields are generally obtained from a fresh bacterial colony.

- Check the codon usage in the recombinant protein sequence for infrequently used codons. Replacing the rare codons with more commonly used codons can significantly increase expression levels. For example, the arginine codons AGG and AGA are used infrequently by E. coli, so the level of tRNAs for these codons is low.

- Add protease inhibitors, such as PMSF, to buffers during protein purification. Use freshly made PMSF, since PMSF loses effectiveness within 30 min of dilution into an aqueous solution.

- If you are using ampicillin for selection in your expression experiments, you may be experiencing plasmid instability due to the absence of selective conditions. This occurs as the ampicillin is destroyed by β-lactamase or hydrolyzed under the acidic media conditions generated by bacterial metabolism. You may want to substitute carbenicillin for ampicillin in your transformation and expression experiments.

- The recombinant protein may be toxic to bacterial cells. Try a tighter regulation system for competent cell expression such as BL21-AI. You may also consider trying a different expression system such as the pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

My cells are growing very slowly, and I'm not getting any protein expression from my baterial expression system. What can I do to fix this?

This typically occurs when your gene of interest is toxic. Try using a tighter regulation system, such as BL21 (DE3) (pLysS) or BL21 (DE3) (pLysE), or BL21(AI).

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

Citations & References (118)

Citations & References
Abstract
Molecular cloning and functional reconstitution of a urate transporter/channel.
Authors:Leal-Pinto E,Tao W,Rappaport J,Richardson M,Knorr BA,Abramson RG
Journal:The Journal of biological chemistry
PubMed ID:8995305
The active conformation of avilamycin A is conferred by AviX12, a radical AdoMet enzyme.
Authors:Boll R,Hofmann C,Heitmann B,Hauser G,Glaser S,Koslowski T,Friedrich T,Bechthold A
Journal:The Journal of biological chemistry
PubMed ID:16537546
Mutational analysis of a fatty acyl-coenzyme A synthetase signature motif identifies seven amino acid residues that modulate fatty acid substrate specificity.
Authors:Black PN,Zhang Q,Weimar JD,DiRusso CC
Journal:The Journal of biological chemistry
PubMed ID:9030548
The neuronal actin-binding proteins, neurabin I and neurabin II, recruit specific isoforms of protein phosphatase-1 catalytic subunits.
Authors:Terry-Lorenzo Ryan T; Carmody Leigh C; Voltz James W; Connor John H; Li Shi; Smith F Donelson; Milgram Sharon L; Colbran Roger J; Shenolikar Shirish;
Journal:J Biol Chem
PubMed ID:12016225
Neurabins are protein phosphatase-1 (PP1) targeting subunits that are highly concentrated in dendritic spines and post-synaptic densities. Immunoprecipitation of neurabin I and neurabin II/spinophilin from rat brain extracts sedimented PP1gamma1 and PP1alpha but not PP1beta. In vitro studies showed that recombinant peptides representing central regions of neurabins also preferentially bound ... More
Unusual binding properties of the SH3 domain of the yeast actin-binding protein Abp1: structural and functional analysis.
Authors: Fazi Barbara; Cope M Jamie T V; Douangamath Alice; Ferracuti Silvia; Schirwitz Katja; Zucconi Adriana; Drubin David G; Wilmanns Matthias; Cesareni Gianni; Castagnoli Luisa;
Journal:J Biol Chem
PubMed ID:11668184
'Abp1p is an actin-binding protein that plays a central role in the organization of Saccharomyces cerevisiae actin cytoskeleton. By a combination of two-hybrid and phage-display approaches, we have identified six new ligands of the Abp1-SH3 domain. None of these SH3-mediated novel interactions was detected in recent all genome high throughput ... More